Skip to main content

MSNVA-T1D Physician Resources

For Physicians and other clinicians who treat patients with Type 1 Diabetes

Building A Preferred Network

Patients newly diagnosed with type 1 diabetes (T1D) often face delays in accessing endocrine care. MSNVA is in the process of creating a preferred directory of endocrinologists and medical practices willing to accept early-stage or high-risk referrals.
This directory will be digitally available to primary care physicians and practices  to reduce referral delays. Please complete the short survey below to add your name/practice to the preferred list.

Lab Oders & Diagnosis Codes

Lab CPT Codes:
-CPT 86337 – Insulin Autoantibody (IAA)
-CPT 86341 – Glutamic Acid Decarboxylase (GAD) Autoantibody
-CPT 86341 – Islet Antigen 2 (IA-2) Autoantibody
-CPT 86341 – Zinc Transporter 8 (ZnT8) Autoantibody
Related Diagnosis Codes:
-Z83.3 – Family history of diabetes
-R73.9 – Hyperglycemia, unspecified
-Z13.1 – Screening for diabetes mellitus

On-Demand Education + CMEs

Access BreakthroughT1D accredited, on-demand type 1 diabetes (T1D) educational webinars available to healthcare professionals. Earn a total of 5.75 contact hours of credit.  Educational webinars include a range of topics in emerging therapies in type 1 diabetes.
Access webinars here

ADA Guidelines

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease progression, type 1 diabetes screening programs are being increasingly emphasized. Once broadly implemented, screening initiatives will identify significant numbers of islet autoantibody–positive (IAb1) children and adults who are at risk for (confirmed single IAb1) or living with (multiple IAb1) early-stage (stage 1 and stage 2) type 1 diabetes.